BMRN

BioMarin Pharmaceutical Inc. News Headlines

$71.22
*  
1.60
2.3%
Get BMRN Alerts
*Delayed - data as of Aug. 29, 2014  -  Find a broker to begin trading BMRN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Can BioMarin Pharmaceutical (BMRN) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
8/27/2014 8:49:00 AM - Zacks.com

7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know
8/26/2014 9:56:04 PM - Motley Fool

NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog
8/7/2014 12:40:00 PM - Zacks.com

Why BioMarin Pharmaceutical (BMRN) Could Beat Earnings Estimates Again - Tale of the Tape
8/7/2014 8:52:00 AM - Zacks.com

Cramer's Mad Money - 4 Charts With Fangs (8/4/14)
8/5/2014 5:52:00 AM - Seeking Alpha

BioMarin Q2 Loss Narrower than Expected, Revenue Guidance Up - Analyst Blog
7/31/2014 5:00:00 PM - Zacks.com

Markets end July undecided
7/31/2014 8:42:00 AM - Market Intelligence Center

BioMarin Sells Priority Review Voucher To Regeneron
7/30/2014 5:42:00 PM - Dow Jones Business News

BioMarin Pharma Q2 Loss Widens - Quick Facts
7/30/2014 5:08:00 PM - RTT News

Biomarin Pharmaceutical Q2 14 Earnings Conference Call At 4:30 PM ET
7/30/2014 3:03:00 PM - RTT News

Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues - Analyst Blog
7/30/2014 12:04:00 PM - Zacks.com

Incyte's Jakafi Fails to Provide RELIEF in Polycythemia Vera - Analyst Blog
7/24/2014 6:30:00 PM - Zacks.com

Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
7/23/2014 2:47:00 PM - Investopedia

Biogen's Q2 Earnings Surpass Expectations, Tecfidera Shines - Analyst Blog
7/23/2014 1:20:00 PM - Zacks.com

Cubist Misses Q2 Earnings Estimates on Weak Cubicin Sales - Analyst Blog
7/23/2014 1:10:00 PM - Zacks.com

bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape
7/21/2014 8:44:00 AM - Zacks.com

Zacks Rank #1 Additions for Friday - Tale of the Tape
7/18/2014 9:30:00 AM - Zacks.com

Repros Gets Additional FDA Guidance for Androxal - Analyst Blog
7/17/2014 5:20:00 PM - Zacks.com

Arena Pharmaceuticals' Pain Candidate Gets New U.S. Patent - Analyst Blog
7/16/2014 4:30:00 PM - Zacks.com

Peregrine Pharmaceuticals' Q4 Loss Narrower than Expected - Analyst Blog
7/15/2014 11:00:00 AM - Zacks.com

Cramer's Lightning Round - BioMarin Deserves To Be Higher (7/14/14)
7/15/2014 6:04:00 AM - Seeking Alpha

Will Johnson & Johnson (JNJ) Beat this Earnings Season? - Analyst Blog
7/14/2014 4:45:00 PM - Zacks.com

BioMarin's Vimizim Gets Canadian Nod - Analyst Blog
7/8/2014 6:10:00 PM - Zacks.com

BioMarin's Vimizim Approved In Canada For Treatment Of Morquio A Syndrome
7/7/2014 8:13:00 AM - RTT News

Why BioMarin Pharmaceutical (BMRN) Could Beat Earnings Estimates Again - Tale of the Tape
7/3/2014 8:57:00 AM - Zacks.com